NCT00994383View on ClinicalTrials.gov

Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled Release

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Pain
Interventions
DRUG

morphine sulfate

morphine sulfate 30 mg tablet, morphine sulfate 15 mg tablet, morphine sulfate controlled release 120 mg

Trial Locations (1)

78759

CEDRA Clinical Research, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00994383 - Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled Release | Biotech Hunter | Biotech Hunter